EMA — authorised 25 January 2010
- Marketing authorisation holder: Merck Sharp & Dohme Limited
- Status: approved
EMA authorised Org 36286 on 25 January 2010
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 25 January 2010.
Merck Sharp & Dohme Limited holds the EU marketing authorisation.